Thanks for that Bilbo35. I checked it out and the following from stock site Seeking Alpha confirms your advice. It certainly sounds promising if accurate and while its about Dendreon not PRR any Dendreon recovery will instill confidence in PRR imo.
"Technical Analysis
Dendreon jumped on Wednesday, November 16 - in fact, the stock was halted for a brief period - after a leader in the Large Urology Group Practice Association, a 10-year-old organization that represent nearly 25% of U.S. urologists, said in a Goldman Sachs conference call that his practice has already placed seven patients on Provenge and has identified 100-200 eligible patients for the drug as well. Further, this practitioner said it was his belief there could be a logarithmic (perhaps "exponential" is a more familiar term (Cohen)) increase in uptake of the drug in 2012 and that there was a need for urologists to embrace Provenge to optimize patient care as they could otherwise risk losing the patients to others who might provide the treatment. The stock immediately jumped to more than $8, was halted, and upon reopening, drifted down to close at $7.51 Wednesday afternoon. The stock closed above $8 on Thursday.
An alternative explanation for the sharp jump in share price on Wednesday, interestingly enough, appeared in the comments section that can be found at the end of an article I wrote earlier this month (Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging). The comment of interest, written by a poster using the pen name "slowtime," posits that the run to $8+ in the stock’s price on...".
http://seekingalpha.com/article/308914-dendreon-new-trial-to-examine-understatement-of-provenge-life-extension-benefits
- Forums
- ASX - By Stock
- good morning saturday
Thanks for that Bilbo35. I checked it out and the following from...
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
33.5¢ |
Change
0.025(8.06%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
32.0¢ | 34.8¢ | 31.3¢ | $1.379M | 4.179M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 170360 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 115131 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35903 | 0.340 |
1 | 826 | 0.335 |
4 | 87150 | 0.330 |
2 | 10200 | 0.325 |
3 | 42625 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 1300 | 1 |
0.335 | 3200 | 1 |
0.340 | 256615 | 3 |
0.345 | 86656 | 4 |
0.350 | 72510 | 6 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online